We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

158 hedge funds and large institutions have $3.61B invested in Loxo Oncology, Inc in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 48 increasing their positions, 55 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 15

32% more capital invested

Capital invested by funds: $2.74B → $3.61B (+$875M)

12% more funds holding

Funds holding: 141 → 158 (+17)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

13% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 55

52% less call options, than puts

Call options by funds: $16.8M | Put options by funds: $34.9M

Holders
158
Holders Change
+17
Holders Change %
+12.06%
% of All Funds
3.62%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
36
Increased
48
Reduced
55
Closed
15
Calls
$16.8M
Puts
$34.9M
Net Calls
-$18M
Net Calls Change
-$18.2M

Top Buyers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
+$42.5M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$39.8M
3
Ameriprise
Ameriprise
Minnesota
+$28.6M
4
TCM
TimesSquare Capital Management
New York
+$23.8M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$15M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$9.91B
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$84.4M
3
Franklin Resources
Franklin Resources
California
-$26.3M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$18M
5
DCM
Driehaus Capital Management
Illinois
-$18M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
101
Suffolk Capital Management
New York
$731K -$457K -4,300 -40%
BFM
102
Boothbay Fund Management
New York
$666K +$614K +5,775 New
VIA
103
Vident Investment Advisory
Georgia
$641K -$204K -1,918 -28%
BNP Paribas Financial Markets
104
BNP Paribas Financial Markets
France
$561K +$8.19K +77 +2%
Teacher Retirement System of Texas
105
Teacher Retirement System of Texas
Texas
$535K -$269K -2,525 -35%
Lazard Asset Management
106
Lazard Asset Management
New York
$524K +$74.7K +702 +18%
Los Angeles Capital Management
107
Los Angeles Capital Management
California
$521K – – –
BI
108
BVF Inc
California
$506K – – –
JMPWA
109
JP Morgan Private Wealth Advisors
California
$502K -$47.9K -450 -9%
TAM
110
Tocqueville Asset Management
New York
$464K +$2.66K +25 +0.6%
BCM
111
BlueCrest Capital Management
Jersey
$463K +$427K +4,015 New
DIA
112
Denver Investment Advisors
Colorado
$442K -$91.3K -858 -18%
JRP
113
Jasper Ridge Partners
California
$399K – – –
DCM
114
Dupont Capital Management
Delaware
$384K +$354K +3,330 New
HSBC Holdings
115
HSBC Holdings
United Kingdom
$374K +$345K +3,248 New
N
116
Nuveen
North Carolina
$373K +$344K +3,231 New
XK
117
Xact Kapitalforvaltning
Sweden
$365K +$74.5K +700 +28%
AB
118
Amalgamated Bank
New York
$352K -$5.74K -54 -2%
SCM
119
Silvant Capital Management
Georgia
$343K +$316K +2,975 New
Canada Life
120
Canada Life
Manitoba, Canada
$342K – – –
Nomura Asset Management
121
Nomura Asset Management
Japan
$342K +$315K +2,960 New
CSS
122
Cubist Systematic Strategies
Connecticut
$321K +$296K +2,780 New
SAM
123
Shell Asset Management
Netherlands
$314K +$290K +2,723 New
Creative Planning
124
Creative Planning
Kansas
$300K +$277K +2,602 New
Prudential Financial
125
Prudential Financial
New Jersey
$294K -$3.78M -35,520 -93%
3 4
5
6 7

LOXO Hedge Fund Activity: Q1 2018 in Review

158 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q1 2018, worth a combined $3.61B — up 32% from $2.74B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new LOXO positions and 15 closed out — a net gain of 21 holders — while 48 added to existing stakes and 55 trimmed.

The largest buyer was Boxer Capital, opening a new position worth an estimated $42.5M. The largest seller was OrbiMed, cutting an estimated $9.91B.

  • 158 institutional investors held Loxo Oncology, Inc (LOXO) as of Q1 2018, up from 141 in Q4 2017.
  • Funds reported $3.61B of Loxo Oncology, Inc stock for Q1 2018, up 32% quarter-over-quarter.
  • 36 funds opened new Loxo Oncology, Inc positions in Q1 2018 and 15 closed out, a net change of +21 holders.
  • The largest Loxo Oncology, Inc buyer in Q1 2018 was Boxer Capital, an estimated $42.5M added.
  • The largest Loxo Oncology, Inc seller in Q1 2018 was OrbiMed, an estimated $9.91B sold.

Based on aggregated 13F filings for Q1 2018.